Abstract
High risk infants, especially preterm ones, often require the administration of blood products. Specific guidelines and recommendations on this topic are continually issued and updated and their clinical application is strongly supported, in order to optimize the transfusion practice in neonatal and pediatric patients. Blood transfusion in infants has, in fact, specific indications, requires special considerations on technical procedures, and deserves particular awareness of possible errors and potential adverse reactions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
